Sector Alpha Week of 2026-08-05
Sector Alpha — machine-written from the numbers · Data as of 2026-08-05

TransDigm Group Incorporated

TDG
Industrials · Aerospace & Defense

TransDigm Group Incorporated's balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup.

The sharpest disagreement: annual EPS moved +25.2% against a −19.6% price move — the market has not yet caught up with the delivery.

The price is in a downtrend (4 weeks in) while the P/E sits at the 9th percentile of its own 4-year range. But the balance sheet is under water: net worth is negative, so shareholders sit behind everyone the company owes. What settles it: whether the business can earn its way back to positive equity before dilution or restructuring gets there first.

Stage
Mixed
partial read
Price
$1,275
−19.6% 1Y
P/E
39.0×
9th pctile
of its own 4-year range
Revenue (Mar 26)
$2.5 B
+18.1% YoY
Profit (Mar 26)
$0.5 B
+12.5% YoY
Operating margin
46.5%
+0.5 pp YoY
ROIC
16.6%
vs WACC 7.8% → +8.8 pp
Cash conversion
107%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

TransDigm Group Incorporated trades at $1,275, in a downtrend and 4 weeks into that stage. That is −0.5% against its own 200-day average. It sits at 44% of a 52-week range of $1,140 to $1,450. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 3 straight weeks.

Today the stock is in a downtrend — week 4 of stage 4. At $1,275 it trades −0.5% versus its 200-day average and sits at 44% of its 52-week range ($1,140–$1,450).

Aug 26: $1,275 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−0.5% versus the 200-day line, week 4 of stage 4
Price50-day avg200-day avg
S2S2S1S4$1,678$1,421$1,164$907$649$$1,275$1,281Jul 23Apr 24Jan 25Oct 25Aug 26
S2S2S1S4$1,678$1,421$1,164$907$649$$1,275$1,281Jul 23Jan 25Aug 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (527 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Jul 16Aug 26

Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +373% while the S&P 500 moved +263% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 3 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

TransDigm Group Incorporated trades at 39.0× P/E, near the bottom of its own range — cheaper only 9% of the time. Its long-run median P/E is 46.1×, measured across 4.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 39.0× is near the bottom of its own range — cheaper only 9% of the time, against a long-run median of 46.1× measured over 4.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

One caveat before moving on: margins are the best this company has ever printed — cheap against its own history on record margins is not the same thing as cheap. If profitability mean-reverts, today's multiple is higher than it looks.

P/E 39.0× vs a 46.1× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly step line (right axis). 4.3-year window; loss-period spikes above 53× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
near the bottom of its own range — cheaper only 9% of the time
P/EMedianEPS (TTM) (quarterly)
54.8×$34.649.7×$26.044.6×$17.339.5×$8.734.4×$0.0×$39.80×$32Apr 22May 23Jun 24Jul 25Aug 26
54.8×$34.649.7×$26.044.6×$17.339.5×$8.734.4×$0.0×$39.80×$32Apr 22Jun 24Aug 26
PEG 2.26 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 19 quarters.
above 1.0, the multiple already banks the growth
PEGPEG = 1.0
3.1×2.5×2.0×1.4×0.8××2.26×Sep 21Sep 22Dec 23Dec 24Mar 26
3.1×2.5×2.0×1.4×0.8××2.26×Sep 21Dec 23Mar 26
P/E
39.0×
9th percentile of 4y
PEG
1.99
as reported

Why the multiple sits where it does: over the past year annual EPS moved +25.2% against a −19.6% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 3y, of the +12.5%/yr price move, ~+19.5%/yr came from earnings growth and ~−7.0 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Mixed

Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

TransDigm Group Incorporated reads as mixed on its fundamental arc. Mixed — the growth curves are steadily positive, but no return curve is held to confirm the Consistent bar. The read is built from 12 quarters across 3 curves, on partial evidence.

Growth, year by year: revenue +11.2% in FY25, profit +20.3% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
22%68%19%54%16%40%13%26%10%12%%%11.2%20.3%FY21FY23FY25
22%68%19%54%16%40%13%26%10%12%%%11.2%20.3%FY21FY23FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue stabilising, profit rolling over
RevenueProfitEPS
25%68%21%52%17%36%14%20%10%3.8%%%13.2%10%8.2%Jul 23Sep 24Mar 26
25%68%21%52%17%36%14%20%10%3.8%%%13.2%10%8.2%Jul 23Sep 24Mar 26
Revenue growth
Steady high
latest +13.2% · span +11.2% to +23.7%
Profit growth
Rolling over
latest +10.0% · span +10.0% to +53.2%
EPS growth
Steady high
latest +8.2% · span +8.2% to +63.8%

Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.

The return-on-capital curve is not shown — net worth is negative, so a return on capital is not a meaningful number in any basis. This is a distressed balance sheet, and the stage is read from the growth curves alone.

A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+11.2%+17.6%
Profit+20.3%+33.5%
EPS+25.2%+33.8%
Stock price−19.6%+12.5%+15.2%+16.3%
Revenue YoY (Mar 26)
+18.1%
latest quarter vs a year ago
Profit YoY (Mar 26)
+12.5%
latest quarter vs a year ago
Revenue 10y
16.5%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

44.8/100 — rank 15 of 30 in Aerospace & Defense · 66% evidence confidence

TransDigm Group Incorporated scores 44.8 out of 100 against the 30 companies it is compared with in Aerospace & Defense, ranking 15. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 16.2 + 15.6 + 5.7 + 7.3 = 44.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

TransDigm Group Incorporated reported $2.5 B of revenue in the Mar 26 quarter, +18.1% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 16.5% a year. The last full year, FY25, came in at $8.8 B. The last four reported quarters add to $9.5 B.

FY25 revenue came in at $8.8 B (+11.2% on the year), capping 4 years at 16.5% compound. The latest quarter (Mar 26) printed $2.5 B, +18.1% year on year — the 12th consecutive quarter of year-over-year growth.

FY25 revenue $8.8 B (+11.2% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
16.5% a year over 4 years
RevenueYoY growth
9.522%7.219%4.816%2.413%0.010%$ B%$9B11.2%FY21FY23FY25
9.522%7.219%4.816%2.413%0.010%$ B%$9B11.2%FY21FY23FY25
Mar 26: $2.5 B (+18.1% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
12th straight quarter of growth
Revenue (quarterly)YoY growth
2.729%2.124%1.419%0.713%0.07.8%$ B%$3B18.1%Jul 23Sep 24Mar 26
2.729%2.124%1.419%0.713%0.07.8%$ B%$3B18.1%Jul 23Sep 24Mar 26

Pace check: the last four quarters averaged +13.2% growth against the decade's 16.5% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +13.2% over the last 4 quarters against +14.1%/yr over the last 8 — stabilising; TTM profit +10.0% vs +16.5%/yr — rolling over.

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

TransDigm Group Incorporated's operating margin is 46.5% in the Mar 26 quarter, +0.5 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged 35.2% to 47.2%. The current quarter sits inside that band.

The latest quarter's operating margin is 46.5%, +0.5 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 35.2%–47.2%, and FY25's 47.2% is the top of that band — a record year.

Why the margin moved: operating margin went +0.5 pp year on year while gross margin went +0.3 pp — the gain came mostly from the gross line: input costs and pricing.

Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.

FY25: 47.2% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
the widest a 35.2–47.2% band over 5 years
operating marginYoY change (pp)
48%5.9%45%4.4%41%2.8%38%1.2%34%−0.3%%%47.2%2.7%FY21FY23FY25
48%5.9%45%4.4%41%2.8%38%1.2%34%−0.3%%%47.2%2.7%FY21FY23FY25
Mar 26: 46.5% operating margin (+0.5 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
49%5.3%47%2.9%46%0.5%44%−1.9%42%−4.3%%%46.5%0.5%Jul 23Sep 24Mar 26
49%5.3%47%2.9%46%0.5%44%−1.9%42%−4.3%%%46.5%0.5%Jul 23Sep 24Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

TransDigm Group Incorporated earned $0.5 B of net profit in the Mar 26 quarter, +12.5% year on year. Full-year FY25 profit was $2.1 B. The 4-year compound rate is 32.1%. That is 21.3% of the quarter's revenue. The same quarter a year earlier earned $0.5 B.

Mar 26 profit was $0.5 B, +12.5% year on year. On the full year, FY25 printed $2.1 B (+20.3%), and the 4-year compound rate is 32.1%.

FY25 profit $2.1 B (+20.3% YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
32.1% a year over 4 years
Net profitYoY growth
2.252%1.743%1.135%0.626%0.018%$ B%$2B20.3%FY21FY23FY25
2.252%1.743%1.135%0.626%0.018%$ B%$2B20.3%FY21FY23FY25
Mar 26: $0.5 B (+12.5% YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
0.771%0.550%0.329%0.27.2%0.0−14%$ B%$1B12.5%Jul 23Sep 24Mar 26
0.771%0.550%0.329%0.27.2%0.0−14%$ B%$1B12.5%Jul 23Sep 24Mar 26

Why profit moved: revenue contributed +18.1% and the margin +0.5 pp — the quarter was revenue-led, with the margin roughly flat.

Pace comparison, last four quarters: profit +10.1% vs revenue +13.2%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 107% of TransDigm Group Incorporated's reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $2.0 B of operating cash against $2.1 B of profit. After $0.2 B of capital spending, $1.8 B was left as free cash.

FY25: operating cash of $2.0 B against reported profit of $2.1 B, leaving free cash of $1.8 B after $0.2 B of capital spending. Across the last 3 fiscal years the conversion rate is 107% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO $2.0 B vs profit $2.1 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 5-year window, annual resolution.
107% of 3-year profit arrived as cash
Operating cashNet profitFree cash
2.21.71.10.60.0$ B$2B$2B$2BFY21FY23FY25
2.21.71.10.60.0$ B$2B$2B$2BFY21FY23FY25
Mar 26: operating cash $0.1 B = 26% of the quarter's profit Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 12 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
0.9197%0.7151%0.4105%0.259%0.013%$ B%$0B26%Jul 23Sep 24Mar 26
0.9197%0.7151%0.4105%0.259%0.013%$ B%$0B26%Jul 23Sep 24Mar 26

Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

TransDigm Group Incorporated does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $1.0 B over the last 3 years. Averaged over those years that is 3.8% of FY25 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $1.0 B over the last 3 fiscal years.

FY25: capex $0.2 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
0.240.180.120.060.00$ B$0BFY21FY23FY25
0.240.180.120.060.00$ B$0BFY21FY23FY25
Mar 26: capex $0.1 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 12 quarters.
Capex (quarterly)Free cash
0.080.80.060.60.040.40.020.20.000.0$ B$ B$0B$0BJul 23Sep 24Mar 26
0.080.80.060.60.040.40.020.20.000.0$ B$ B$0B$0BJul 23Sep 24Mar 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

TransDigm Group Incorporated earns a ROE of −21% in FY25. That is up from a trough of −66% in FY23. Return on invested capital clears the cost of that capital by +8.8 percentage points, so growth here adds value rather than only size. The wiring behind it is 23.4% net margin on 0.39× asset turns.

FY25 ROE is −21%, recovered from a FY23 trough of −66% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY25): 23.4% net margin × 0.39× asset turns × −2.37× balance-sheet leverage ≈ −21.6% on equity. Margin is doing the heavy lifting; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 16.6% − 7.8% = a +8.8 pp spread. The 7.8% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. A spread this wide means every dollar reinvested creates more than a dollar of value — the engine compounds.

FY25: ROE −21% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included. Dashed line = the 7.8% cost of capital used on this page.
the climb back from FY23's −66%
ROEROIC (annual)WACC
23%0.0%−25%−48%−72%%−21.4%16.4%FY21FY23FY25
23%0.0%−25%−48%−72%%−21.4%16.4%FY21FY23FY25
Mar 26: ROIC 16.6% (TTM) vs WACC 7.8% Trailing-twelve-month ROIC and ROE, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)WACC
23%0.9%−21%−42%−64%%16.6%−33.5%Jul 23Sep 24Mar 26
23%0.9%−21%−42%−64%%16.6%−33.5%Jul 23Sep 24Mar 26
11 · Dividend

Dividend

TransDigm Group Incorporated pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.

TransDigm Group Incorporated does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.

12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

TransDigm Group Incorporated's net worth is negative — it owes more than it owns — so a debt-to-equity ratio is not meaningful here. On the annual view that ratio went from −6.87 in FY21 to −3.10 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of $32.0 B against shareholder equity of $−9.4 B — a debt-to-equity of −3.41. On the annual view, debt-to-equity went from −6.87 (FY21) to −3.10 (FY25). The returns on this page are earned, not borrowed.

FY25: debt $30.0 B at −3.10× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
32−2.6×24−4.5×16−6.5×8.1−8.5×0.0−10.5×$ B×$30B−3.10×FY21FY23FY25
32−2.6×24−4.5×16−6.5×8.1−8.5×0.0−10.5×$ B×$30B−3.10×FY21FY23FY25
Mar 26: debt $32.0 B, debt-to-equity −3.41 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
35−2.6×26−4.5×17−6.5×8.6−8.5×0.0−10.5×$ B×$32B−3.41×Jul 23Sep 24Mar 26
35−2.6×26−4.5×17−6.5×8.6−8.5×0.0−10.5×$ B×$32B−3.41×Jul 23Sep 24Mar 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

1.9% of TransDigm Group Incorporated's tradable float is currently sold short — the crowd is not positioned against this stock. At typical trading volumes those positions would take about 2.6 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 1.9% of the float is sold short, and at typical trading volumes it would take about 2.6 days to buy those positions back. The crowd is not positioned against this stock. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
1.9%
of the tradable float
Days to cover
2.6
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

TransDigm Group Incorporated: the Z-score reads 2.04. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits in the grey band between the two. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

Why it matters: a Z-score of 2.04 sits in the grey band — neither clearly safe nor clearly distressed.

The safety line in one sentence: the Z-score reads 2.04.

15 · Related companies · Aerospace & Defense
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1HEICO CorporationHEI 67.7/100Favorable setup81% evidence BREAKING OUT 24.4/35 Revenue 18.8% · PAT 30.2% · OPM change 2.9 pp 83% evidence 15.5/25 ROCE 4.3% · OPM 25.5% 76% evidence 10.5/20 P/E 48.2× · PEG 1.56 65% evidence 17.3/20 RS sector 5% · RS bench 3.6% · 1Y 17.3%8 of 12 weeks ahead 100% evidence
Exact sum: 24.4 + 15.5 + 10.5 + 17.3 = 67.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Howmet Aerospace Inc.HWM 65.9/100Favorable setup66% evidence TURNING 22.6/35 Revenue 14.2% · PAT 38.9% · OPM change 7.2 pp 53% evidence 15.9/25 ROCE 7.5% · OPM 32.6% 57% evidence 11.2/20 P/E 53.5× · PEG 1.32 65% evidence 16.2/20 RS sector 16.2% · RS bench 13.9% · 1Y 59.4%2 of 12 weeks ahead 100% evidence
Exact sum: 22.6 + 15.9 + 11.2 + 16.2 = 65.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3Elbit Systems Ltd.ESLT 59.7/100Mixed-positive evidence66% evidence TURNING 20.6/35 Revenue 14.8% · PAT 66.9% · OPM change 1.5 pp 53% evidence 12.3/25 ROCE 3.1% · OPM 9.4% 57% evidence 11.6/20 P/E 68.8× · PEG 1.21 65% evidence 15.2/20 RS sector 16.5% · RS bench 13.3% · 1Y 89%0 of 12 weeks ahead 100% evidence
Exact sum: 20.6 + 12.3 + 11.6 + 15.2 = 59.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Lockheed Martin CorporationLMT 59.3/100Thin evidence · provisional56% evidence TURNING 19.6/35 Revenue — · PAT — · OPM change -1.8 pp 39% evidence 15.2/25 ROCE 6.8% · OPM 11.4% 76% evidence 11.1/20 P/E 18.7× · PEG — 15% evidence 13.4/20 RS sector 1.2% · RS bench -1.1% · 1Y 38.5%3 of 12 weeks ahead 100% evidence
Exact sum: 19.6 + 15.2 + 11.1 + 13.4 = 59.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
5Hexcel CorporationHXL 58.7/100Thin evidence · provisional56% evidence FADING 21.0/35 Revenue — · PAT — · OPM change 1.8 pp 39% evidence 11.4/25 ROCE 2.9% · OPM 11.5% 76% evidence 9.8/20 P/E 50.3× · PEG — 15% evidence 16.5/20 RS sector 17.4% · RS bench 15.2% · 1Y 72.6%8 of 12 weeks ahead 100% evidence
Exact sum: 21 + 11.4 + 9.8 + 16.5 = 58.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
6RTX CorporationRTX 58.2/100Thin evidence · provisional56% evidence TURNING 19.1/35 Revenue — · PAT — · OPM change 1.6 pp 39% evidence 10.6/25 ROCE 2.5% · OPM 11.6% 76% evidence 10.8/20 P/E 33.4× · PEG — 15% evidence 17.7/20 RS sector 8.6% · RS bench 6.5% · 1Y 40.7%3 of 12 weeks ahead 100% evidence
Exact sum: 19.1 + 10.6 + 10.8 + 17.7 = 58.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
7GE AerospaceGE 57.7/100Mixed-positive evidence81% evidence BREAKING OUT 18.8/35 Revenue 21.7% · PAT 18.8% · OPM change 0.3 pp 83% evidence 11.8/25 ROCE 2.9% · OPM 18.9% 76% evidence 8.6/20 P/E 43.9× · PEG 2.09 65% evidence 18.5/20 RS sector 10.7% · RS bench 9% · 1Y 37.2%8 of 12 weeks ahead 100% evidence
Exact sum: 18.8 + 11.8 + 8.6 + 18.5 = 57.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8Woodward, Inc.WWD 56.9/100Thin evidence · provisional56% evidence ASLEEP 20.5/35 Revenue — · PAT — · OPM change 1.2 pp 39% evidence 15.1/25 ROCE 4.9% · OPM 14.7% 76% evidence 9.7/20 P/E 50.5× · PEG — 15% evidence 11.6/20 RS sector 4.5% · RS bench 2.1% · 1Y 50.5%3 of 12 weeks ahead 100% evidence
Exact sum: 20.5 + 15.1 + 9.7 + 11.6 = 56.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
9Leonardo DRS, Inc.DRS 55.2/100Thin evidence · provisional56% evidence TURNING 20.7/35 Revenue — · PAT — · OPM change 1.7 pp 39% evidence 12.4/25 ROCE 3.3% · OPM 9.1% 76% evidence 10.5/20 P/E 35.9× · PEG — 15% evidence 11.6/20 RS sector -0.5% · RS bench -2.1% · 1Y 9.1%2 of 12 weeks ahead 100% evidence
Exact sum: 20.7 + 12.4 + 10.5 + 11.6 = 55.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
10General Dynamics CorporationGD 54.9/100Thin evidence · provisional56% evidence BREAKING OUT 17.3/35 Revenue — · PAT — · OPM change 0.5 pp 39% evidence 13.1/25 ROCE 3.7% · OPM 10.5% 76% evidence 11.0/20 P/E 22.8× · PEG — 15% evidence 13.5/20 RS sector 1.5% · RS bench -0.1% · 1Y 22.8%3 of 12 weeks ahead 100% evidence
Exact sum: 17.3 + 13.1 + 11 + 13.5 = 54.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
11Curtiss-Wright CorporationCW 54.2/100Mixed-positive evidence66% evidence ASLEEP 18.8/35 Revenue 12.2% · PAT 19.1% · OPM change 1.5 pp 53% evidence 14.1/25 ROCE 4% · OPM 17.5% 57% evidence 7.3/20 P/E 49.9× · PEG 2.33 65% evidence 14.0/20 RS sector 9.1% · RS bench 6.8% · 1Y 60.3%0 of 12 weeks ahead 100% evidence
Exact sum: 18.8 + 14.1 + 7.3 + 14 = 54.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Embraer S.A.EMBJ 53.0/100Mixed-positive evidence66% evidence TURNING 16.3/35 Revenue 20% · PAT -22.2% · OPM change 1 pp 53% evidence 7.9/25 ROCE 1.1% · OPM 5.6% 57% evidence 14.3/20 P/E 54.9× · PEG 0.51 65% evidence 14.5/20 RS sector 1.9% · RS bench 0.2% · 1Y 20.8%2 of 12 weeks ahead 100% evidence
Exact sum: 16.3 + 7.9 + 14.3 + 14.5 = 53 · Decision use: Price leads the evidence: RS versus the benchmark is 0.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
13StandardAero, Inc.SARO 52.4/100Thin evidence · provisional56% evidence TURNING 18.3/35 Revenue 15% · PAT 100% · OPM change -0.2 pp 53% evidence 9.5/25 ROCE 2.8% · OPM 8.8% 57% evidence 10.9/20 P/E 29.4× · PEG — 15% evidence 13.7/20 RS sector 0.7% · RS bench -1% · 1Y 11.3%3 of 12 weeks ahead 100% evidence
Exact sum: 18.3 + 9.5 + 10.9 + 13.7 = 52.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
14Axon Enterprise, Inc.AXON 48.0/100Thin evidence · provisional56% evidence BREAKING OUT 19.3/35 Revenue 34% · PAT -37.8% · OPM change 5.1 pp 53% evidence 8.1/25 ROCE 0.6% · OPM 3.6% 57% evidence 8.6/20 P/E 170.6× · PEG — 15% evidence 12.0/20 RS sector -1.7% · RS bench -2.1% · 1Y -27.9%6 of 12 weeks ahead 100% evidence
Exact sum: 19.3 + 8.1 + 8.6 + 12 = 48 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
15TransDigm Group Incorporatedthis pageTDG 44.8/100Mixed-negative evidence66% evidence TURNING 16.2/35 Revenue 13.3% · PAT 9.6% · OPM change 0.2 pp 53% evidence 15.6/25 ROCE 5.5% · OPM 46.3% 57% evidence 5.7/20 P/E 35.6× · PEG 4.36 65% evidence 7.3/20 RS sector -10.2% · RS bench -11.3% · 1Y -8.3%0 of 12 weeks ahead 100% evidence
Exact sum: 16.2 + 15.6 + 5.7 + 7.3 = 44.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16Northrop Grumman CorporationNOC 44.8/100Thin evidence · provisional56% evidence BASING 17.4/35 Revenue — · PAT — · OPM change 3.9 pp 39% evidence 11.2/25 ROCE 3% · OPM 10% 76% evidence 11.5/20 P/E 16.2× · PEG — 15% evidence 4.7/20 RS sector -16.6% · RS bench -18.2% · 1Y -5.1%0 of 12 weeks ahead 100% evidence
Exact sum: 17.4 + 11.2 + 11.5 + 4.7 = 44.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
17Huntington Ingalls Industries, Inc.HII 42.5/100Thin evidence · provisional56% evidence ASLEEP 16.5/35 Revenue — · PAT — · OPM change -0.9 pp 39% evidence 9.5/25 ROCE 2.2% · OPM 5% 76% evidence 11.4/20 P/E 16.7× · PEG — 15% evidence 5.1/20 RS sector -11.3% · RS bench -13.5% · 1Y 22.1%0 of 12 weeks ahead 100% evidence
Exact sum: 16.5 + 9.5 + 11.4 + 5.1 = 42.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
18CAE Inc.CAE 42.3/100Mixed-negative evidence66% evidence BASING 10.5/35 Revenue 4.4% · PAT -22.4% · OPM change -7.6 pp 53% evidence 10.8/25 ROCE 2% · OPM 12.9% 57% evidence 14.8/20 P/E 37.3× · PEG 0.68 65% evidence 6.2/20 RS sector -11.8% · RS bench -13.2% · 1Y -6.2%0 of 12 weeks ahead 100% evidence
Exact sum: 10.5 + 10.8 + 14.8 + 6.2 = 42.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
19Textron Inc.TXT 41.5/100Thin evidence · provisional56% evidence BASING 15.6/35 Revenue — · PAT — · OPM change -0.8 pp 39% evidence 9.4/25 ROCE 2% · OPM 6.3% 76% evidence 11.3/20 P/E 17.4× · PEG — 15% evidence 5.2/20 RS sector -7.9% · RS bench -9.5% · 1Y 15.7%1 of 12 weeks ahead 100% evidence
Exact sum: 15.6 + 9.4 + 11.3 + 5.2 = 41.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
20The Boeing CompanyBA 39.9/100Thin evidence · provisional56% evidence BASING 16.4/35 Revenue — · PAT — · OPM change -0.4 pp 39% evidence 4.6/25 ROCE 0.3% · OPM 2% 76% evidence 9.0/20 P/E 93.7× · PEG — 15% evidence 9.9/20 RS sector -1.6% · RS bench -3.1% · 1Y 3.5%0 of 12 weeks ahead 100% evidence
Exact sum: 16.4 + 4.6 + 9 + 9.9 = 39.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
21FTAI Aviation Ltd.FTAI 39.8/100Thin evidence · provisional56% evidence ASLEEP 12.5/35 Revenue — · PAT — · OPM change -9.6 pp 39% evidence 14.3/25 ROCE 5% · OPM 20.5% 76% evidence 9.2/20 P/E 58.8× · PEG — 15% evidence 3.8/20 RS sector -5.3% · RS bench -7.9% · 1Y 63.1%0 of 12 weeks ahead 100% evidence
Exact sum: 12.5 + 14.3 + 9.2 + 3.8 = 39.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
22L3Harris Technologies, Inc.LHX 39.7/100Thin evidence · provisional53% evidence BASING 17.9/35 Revenue — · PAT — · OPM change 1.2 pp 32% evidence 10.3/25 ROCE 1.9% · OPM 11.4% 76% evidence 8.9/20 P/E 96× · PEG — 15% evidence 2.6/20 RS sector -15.5% · RS bench -17.3% · 1Y 5.8%0 of 12 weeks ahead 100% evidence
Exact sum: 17.9 + 10.3 + 8.9 + 2.6 = 39.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
23AeroVironment, Inc.AVAV 37.3/100Mixed-negative evidence71% evidence BASING 17.6/35 Revenue 100% · PAT -702.3% · OPM change 3.9 pp 83% evidence 6.4/25 ROCE 1.8% · OPM 8.9% 76% evidence 8.7/20 P/E 97.8× · PEG — 15% evidence 4.6/20 RS sector -36.8% · RS bench -37.6% · 1Y -31.7%0 of 12 weeks ahead 100% evidence
Exact sum: 17.6 + 6.4 + 8.7 + 4.6 = 37.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24BWX Technologies, Inc.BWXT 34.2/100Adverse evidence66% evidence BASING 16.3/35 Revenue 21.4% · PAT 19% · OPM change -1.8 pp 53% evidence 11.4/25 ROCE 2.7% · OPM 9.9% 57% evidence 5.3/20 P/E 54.7× · PEG 2.86 65% evidence 1.2/20 RS sector -18% · RS bench -19.5% · 1Y -3.8%0 of 12 weeks ahead 100% evidence
Exact sum: 16.3 + 11.4 + 5.3 + 1.2 = 34.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25Kratos Defense & Security Solutions, Inc.KTOS 33.9/100Thin evidence · provisional56% evidence BASING 18.0/35 Revenue 21.9% · PAT 50% · OPM change -0.9 pp 53% evidence 6.6/25 ROCE 0.2% · OPM 1.3% 57% evidence 8.5/20 P/E 423.2× · PEG — 15% evidence 0.8/20 RS sector -36.5% · RS bench -37.9% · 1Y -18.8%0 of 12 weeks ahead 100% evidence
Exact sum: 18 + 6.6 + 8.5 + 0.8 = 33.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
26Planet Labs PBCPL 30.2/100Adverse evidence61% evidence ASLEEP 13.8/35 Revenue 34% · PAT — · OPM change -2.7 pp 62% evidence 3.4/25 ROCE -4.8% · OPM -37.1% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 3.0/20 RS sector -6.5% · RS bench -9.9% · 1Y 256.7%4 of 12 weeks ahead 100% evidence
Exact sum: 13.8 + 3.4 + 10 + 3 = 30.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Honeywell Aerospace Inc.HONA 55.0/100Thin evidence · provisional18% evidence 17.7/35 Revenue — · PAT — · OPM change -4.3 pp 10% evidence 17.3/25 ROCE 14.4% · OPM 20.2% 57% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence
Exact sum: 17.7 + 17.3 + 10 + 10 = 55 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
28Moog Inc.MOG-B 54.0/100Thin evidence · provisional33% evidence BREAKING OUT 19.6/35 Revenue — · PAT — · OPM change 1 pp 32% evidence 14.0/25 ROCE 4.4% · OPM 10.8% 76% evidence 10.4/20 P/E 36.1× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y 101.5%8 of 11 weeks ahead 0% evidence
Exact sum: 19.6 + 14 + 10.4 + 10 = 54 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
29Rocket Lab CorporationRKLB 42.4/100Thin evidence · provisional48% evidence FADING 22.4/35 Revenue 45.7% · PAT — · OPM change 20.4 pp 40% evidence 6.0/25 ROCE -3.4% · OPM -27.9% 57% evidence 10.0/20 P/E — · PEG — 0% evidence 4.0/20 RS sector -5.1% · RS bench -7.4% · 1Y 66.6%8 of 12 weeks ahead 100% evidence
Exact sum: 22.4 + 6 + 10 + 4 = 42.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
30Space Exploration Technologies Corp.SPCX 41.7/100Thin evidence · provisional18% evidence 16.3/35 Revenue — · PAT — · OPM change -42.1 pp 10% evidence 5.4/25 ROCE -5% · OPM -41.4% 57% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence
Exact sum: 16.3 + 5.4 + 10 + 10 = 41.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is TransDigm Group Incorporated's stock price today?

TransDigm Group Incorporated trades at $1,275, −19.6% over the past year. The company is valued at $71.0 B. The stock sits at 44% of its 52-week range of $1,140–$1,450, −0.5% versus its 200-day average. On the tape, the price is in a downtrend, 4 weeks in. — as of 5 August 2026.

What were TransDigm Group Incorporated's latest quarterly results?

TransDigm Group Incorporated reported revenue of $2.5 B and net profit of $0.5 B for the Mar 26 quarter. Revenue rose 18.1% and profit rose 12.5% year on year. Earnings per share were $9.20. The operating margin was 46.5%, 0.5 pp higher than a year earlier. — as of 5 August 2026.

What is TransDigm Group Incorporated's revenue?

TransDigm Group Incorporated reported revenue of $2.5 B in the Mar 26 quarter, +18.1% year on year. For the full FY25 fiscal year, revenue was $8.8 B (+11.2%). Over the last 4 years revenue compounded at 16.5% a year. — as of 5 August 2026.

What is TransDigm Group Incorporated's profit?

TransDigm Group Incorporated earned $0.5 B of net profit in the Mar 26 quarter, +12.5% year on year. Full-year FY25 profit was $2.1 B. The operating margin ran 46.5% in the latest quarter. — as of 5 August 2026.

What is TransDigm Group Incorporated's market cap?

TransDigm Group Incorporated's market capitalisation is $71.0 B at a stock price of $1,275. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.

What is TransDigm Group Incorporated's P/E ratio?

TransDigm Group Incorporated trades at a P/E of 39.0×, at the 9th percentile of its own 4-year range, against a long-run median of 46.1×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.

Does TransDigm Group Incorporated pay a dividend?

No — TransDigm Group Incorporated has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.

Is TransDigm Group Incorporated overvalued?

On its own history, TransDigm Group Incorporated looks cheap against its own history: its P/E of 39.0× has been cheaper only 9% of the time in 4 years (long-run median 46.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 5 August 2026.

Is TransDigm Group Incorporated growing?

Yes — TransDigm Group Incorporated is growing: latest-quarter revenue +18.1% year on year, profit +12.5%, and the margin +0.5 pp at 46.5%. The 4-year compound rates are 16.5% (revenue) and 32.1% (profit). The earnings engine currently reads: improving — as of 5 August 2026.

How is TransDigm Group Incorporated performing?

TransDigm Group Incorporated is in a downtrend, 4 weeks in. Its latest quarter's revenue rose 18.1% and profit rose 12.5% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 3 weeks. This describes what the data did, not a rating. — as of 5 August 2026.

What stage is TransDigm Group Incorporated in?

Mixed — the growth curves are steadily positive, but no return curve is held to confirm the Consistent bar. The read comes from the last 12 quarters of growth (revenue growth +13.2% latest, profit growth +10.0% latest, eps growth +8.2% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.

Is TransDigm Group Incorporated in an uptrend?

No — the price is in a downtrend (week 4 of stage 4), trading −0.5% versus its 200-day average and at 44% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.

Is TransDigm Group Incorporated beating the market?

On recent form, yes — TransDigm Group Incorporated has been ahead of the S&P 500 on a trailing-13-week view for 3 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +373% against the S&P 500's +263% — ahead of the index over the full window. — as of 5 August 2026.

Will TransDigm Group Incorporated's stock price go up?

This page publishes no price forecast for TransDigm Group Incorporated. What it measures instead: the stock price is $1,275, the price is in a downtrend 4 weeks in. Its P/E of 39.0× sits at the 9th percentile of its own 4-year range. — as of 5 August 2026.

Is the market betting against TransDigm Group Incorporated?

No — short interest is 1.9% of TransDigm Group Incorporated's tradable float, about 2.6 days to cover at typical volumes. That is a low reading: the crowd is not positioned against this stock. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.

What is TransDigm Group Incorporated's capex?

TransDigm Group Incorporated spent $1.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.2 B. — as of 5 August 2026.

What is TransDigm Group Incorporated's cash flow?

TransDigm Group Incorporated generated $2.0 B of operating cash flow in FY25 and $1.8 B of free cash flow after $0.2 B of capital spending. Reported profit that year was $2.1 B, so operating cash ran behind profit. — as of 5 August 2026.

Is TransDigm Group Incorporated's profit real cash?

Yes — over the last 3 fiscal years, 107% of TransDigm Group Incorporated's reported profit arrived as operating cash. In FY25, operating cash was $2.0 B against reported profit of $2.1 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.

How financially safe is TransDigm Group Incorporated?

On the balance sheet, the Z-score reads 2.04 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is in the grey band — neither clearly safe nor clearly distressed. — as of 5 August 2026.

Where is TransDigm Group Incorporated in its business cycle?

TransDigm Group Incorporated's FY25 operating margin was 47.2%, against a 5-year band of 35.2%–47.2%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 46.5%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.

What could break the TransDigm Group Incorporated story?

The sharpest disagreement: annual EPS moved +25.2% against a −19.6% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.

Is TransDigm Group Incorporated a stock worth studying right now?

This is not investment advice. The machine read: TransDigm Group Incorporated's balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup. The sharpest open question: whether the business can earn its way back to positive equity before dilution or restructuring gets there first. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI